P/E ratio for Neogen (NEOG)
P/E ratio as of April 2024 (TTM): -104
According to Neogen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -103.595. At the end of 2022 the company had a P/E ratio of 312.
P/E ratio history for Neogen from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 312 | 269.09% |
| 2021 | 84.6 | 21.18% |
| 2020 | 69.8 | 22.24% |
| 2019 | 57.1 | 26.46% |
| 2018 | 45.2 | -25.81% |
| 2017 | 60.9 | -4.13% |
| 2016 | 63.5 | 6.1% |
| 2015 | 59.9 | 0.93% |
| 2014 | 59.3 | -0.69% |
| 2013 | 59.7 | 37.62% |
| 2012 | 43.4 | 33.47% |
| 2011 | 32.5 | -28.84% |
| 2010 | 45.7 | 32.02% |
| 2009 | 34.6 | 28.81% |
| 2008 | 26.9 | -23.79% |
| 2007 | 35.3 | 44.47% |
| 2006 | 24.4 | -20.42% |
| 2005 | 30.7 | -6.11% |
| 2004 | 32.7 | 10.94% |
| 2003 | 29.4 | 47.65% |
| 2002 | 19.9 | -32.82% |
| 2001 | 29.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 37.6 | -136.33% | 🇺🇸 USA |
 Becton Dickinson BDX | 42.1 | -140.67% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 49.9 | -148.14% | 🇺🇸 USA |
 Illumina ILMN | -4.62 | -95.54% | 🇺🇸 USA |
 Danaher DHR | 31.2 | -130.14% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -114.45% | 🇺🇸 USA |
 Pacific Biosciences
PACB | -1.07 | -98.97% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 35.0 | -133.81% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.